ADV SCI 润色咨询

Advanced Science

出版年份:暂无数据 年文章数:3863 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2024-04-04 123cda67m26(暂无昵称) 来自上海

    怎么这么慢,with editory已经9天了

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2023-08-12 124a8810m95(暂无昵称) 来自重庆

    这个期刊和大CDD比起来怎么样啊?

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2024-04-13 ms9000000188651574 来自吉林省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:生物医学;代谢;疾病
    经验分享:2024.03.06 Manuscript Submitted
    2024.03.12 With Editor
    2024.03.12 Under Review
    2024.04.11 Reject
    提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2023-09-25 ms3000001364437971 来自北京

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:医学工程
    经验分享:3.15submit
    3.21under review
    4.10返修
    4.28再投递
    6.6拒稿
    23.6.27 申诉后重新submit
    23.8.7返回
    23.8.24 resubmit
    23.9.23 接收

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2024-04-04 小小子 来自江苏省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:生命科学
    经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2024-02-04 12315a97m77暂无昵称 来自四川省

    偏重的研究方向:医学;生物材料;核酸纳米材料
    经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2022-12-14 ms6000000798925478 来自广东省

    12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2024-01-08 xiaozou_up20 来自广西

    有没有大佬投稿快3周了还是submitted的

    10

    展开10条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2023-12-29 1464e744m37暂无昵称 来自上海

    投稿21天还是manuscript submitted

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢,with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:生物医学;代谢;疾病<br>经验分享:2024.03.06 Manuscript Submitted<br>2024.03.12 With Editor<br>2024.03.12 Under Review<br>2024.04.11 Reject<br>提交之后很快送审,两个审稿人,审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表,但仍未改变审稿人的固有印象,其意见也十分不专业,并且严重缺乏本研究的相关背景知识,并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见,其中有两个实验上的补充验证。总的来说体验不算很好,但是审稿速度相对较快,上升类期刊,有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学工程<br>经验分享:3.15submit<br>3.21under review<br>4.10返修<br>4.28再投递<br>6.6拒稿<br>23.6.27 申诉后重新submit<br>23.8.7返回<br>23.8.24 resubmit<br>23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学<br>经验分享:投稿一个月不到,送审后被拒,两个审稿人,第二个审稿人就两个小问题,其中一个问题文中已经解决,但对方没认真看文章,最恶心是第一个审稿人,问了一大堆很不专业的问题,而且绝大部分问题在文稿中也早就有研究结果了,他还在那说这里没有证据那里没有证据,看意见的表达风格好像国人,严重怀疑是学生审的,很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向:医学;生物材料;核酸纳米材料<br>经验分享:有一审后是received reviews completed的友友吗,一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted,一直到今天都没有变化,是凉凉了嘛?生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2177939, encodeId=acc921e793999, content=投稿21天还是manuscript submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Fri Dec 29 10:15:54 CST 2023, time=2023-12-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆)]
    2024-01-23 1522336 来自重庆

    请问with editor大概多久能有消息? 已经一周多了

    15

    展开15条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分